Equinox Group

Since 1995, Equinox Group has provided analytics to support R&D decisions at biopharmaceutical firms in over projects, assessing the potential of drugs from discovery to launch, and anywhere in between. Our validated techniques will save our clients' time and money, as well as overcome the deficiencies of traditional market research. Our specialties include: • Assessing the value of drugs in R&D • Disease area strategy • Market access • Patient share forecasting • Epidemiology & patient flow modeling We have evaluated thousands of drug profiles across hundreds of indications in oncology, immunology, rare diseases, cardio-metabolic disorders, infectious diseases, neurology, respiratory, urology, ophthalmology, and endocrine disorders. We also have tailored methods to solve the unique analytical challenges that arise in oncology and rare diseases.